Public Health Intervention Package for COVID-19

Phase-Based Progress Estimates
COVID-19+4 More
Public Health Intervention Package - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing a public health intervention to make COVID-19 testing more acceptable and accessible to underserved populations in the US who are at a higher risk of acquiring COVID-19.

Eligible Conditions
  • COVID-19
  • COVID19 (disease)

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: At time of enrollment and every 2 months for up to 12 months (for a total of 7 time points)

Month 12
COVID-19 Testing Attitudes Score
COVID-19 Testing Knowledge Score
Month 12
Campaign Exposure Questionnaire
Month 12
Recommended testing proportion

Trial Safety

Trial Design

1 Treatment Group

COVID-19 Testing
1 of 1
Experimental Treatment

150 Total Participants · 1 Treatment Group

Primary Treatment: Public Health Intervention Package · No Placebo Group · N/A

COVID-19 Testing
Experimental Group · 1 Intervention: Public Health Intervention Package · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at time of enrollment and every 2 months for up to 12 months (for a total of 7 time points)

Who is running the clinical trial?

62 Previous Clinical Trials
38,406 Total Patients Enrolled
Kathleen FairfieldLead Sponsor
Kathleen Fairfield, MD, DrPHPrincipal InvestigatorMaineHealth

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are an individual who immigrated to the United States, primarily from one of these six country groups - Somalia, Angola, Iraq or Syria, Burundi or Rwanda, Democratic Republic of the Congo, or a country in Latin America.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: October 5th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%